11/21/2024
5:14 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
12:44 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:01 PM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Knight Therapeutics Inc (Filed by)
| Form SC 13G/A | |
11/06/2024
4:26 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
2:46 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
10/08/2024
7:17 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
9:56 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form PRE 14A | |
|
09/30/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
09/19/2024
3:30 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/11/2024
3:46 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
2:59 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
9:29 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
11:03 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
12:21 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/24/2024
4:05 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/22/2024
10:23 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/18/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
07/16/2024
4:28 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:02 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/09/2024
2:37 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:06 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:26 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
1:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
05/21/2024
7:22 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:23 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
TOOVEY STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:23 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:18 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Allen Charles W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:19 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:20 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
FIELD PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
10:56 AM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:19 PM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G/A | |
04/03/2024
5:00 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
1:32 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/02/2024
2:31 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
2:33 PM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
11:15 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
01/22/2024
4:01 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
1:56 PM | 60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
9:29 AM | 60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G | |
12/18/2023
8:23 AM | 60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad) A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation.
In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come. Click here now to watch the full briefing and discover the steps to take today. |
